Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Rx Implementing Regs Expected After July 4

This article was originally published in The Pink Sheet Daily

Executive Summary

CMS is understood to be nearing completion on Title II (Medicare Advantage) regs. However, the current plan is to release Title I (Medicare Part D) and Title II on the same day.

You may also be interested in...



Medicare Advantage Rule At OMB

The Office of Management & Budget is reviewing the Centers for Medicare & Medicaid Services' proposed implementing regulations for Title II (Medicare Advantage) of the Medicare Rx law.

Medicare Advantage Rule At OMB

The Office of Management & Budget is reviewing the Centers for Medicare & Medicaid Services' proposed implementing regulations for Title II (Medicare Advantage) of the Medicare Rx law.

CMS Final Rule Defining “Average Sales Price” Expected In 2007

The Centers for Medicare & Medicaid Services' interim final rule defining "average sales price" is expected to be replaced with a final rule in April 2007, HHS' semiannual regulatory agenda published in the June 28 Federal Register states

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS059798

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel